options available to patients with tp53-mutated mds beyond stem cell transplantation
Published 9 months ago • 270 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
1:25
should patients with tp53-mutated mds receive stem cell transplant?
-
1:27
treatment options for patients with tp53-mutated aml
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
3:56
treatment approaches for patients with tp53-mutated mcl
-
3:19
an overview of novel treatment approaches in tp53-mutated aml
-
1:20
impact of tp53 mutations on outcomes in myelofibrosis
-
1:27
tp53-aberrant mcl: challenges and treatment approaches
-
4:22
icount 3ts - 3 part hematology system 7 reasons for you to choose ! 70 tests per hour !
-
4:07
stem cell boost for persistent cytopenia after car-t therapy
-
8:14
progress in the treatment of tp53 mutated aml
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
5:18
upfront treatment in transplant candidates
-
2:53
the utility of cd34-selected peripheral blood stem cell graft as gvhd prevention in hla allografts
-
0:51
key unmet needs in the treatment of immune-mediated ttp
-
1:41
transplant optimization strategies
-
1:47
identifying positive regulators of t cell functions to improve cellular therapies
-
3:41
automate to control
-
1:02
the use of car-t cell products in a real-world setting
-
2:48
virus-specific t cells - effectiveness, safety profile and use
-
1:10
immunotherapy and its dependence on t-cells
-
0:52
the role and clinical use of tpo receptor agonists in the treatment of itp
-
2:20
ebmt diagnostic criteria for tma post-allosct and the role of complement activation